Cytomegalovirus retinitis in AIDS patients: a clinical review. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Cytomegalovirus retinitis in AIDS patients: a clinical review.

Bol Asoc Med P R. 1994 Jul-Sep;86(7-9):62-7. Unique Identifier : AIDSLINE MED/95032420
Vendrell CP; Ramirez-Ronda CH; Infectious Diseases Program, University of Puerto Rico School of; Medicine, San Juan.

Abstract: Cytomegalovirus (CMV) retinitis is an ocular condition previously seen in organ transplant recipients, patient on chemotherapy for malignancy, and in infants with congenital infections. As it present in immunocompromised, the AIDS patient has integrated this group of patients that can present with CMV retinitis. Moreover, it is the leading cause of opportunistic ocular infection in the AIDS patient, and the second most common ocular manifestation. As new drugs and modes of administration are studied that can effectively halt this progressively blinding condition, the awareness and recognition of CMV retinitis on AIDS patients has become increasingly important. This author will review the epidemiology, clinical presentation, and differential diagnosis of this condition. The current treatments being used and complications will also be discussed.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS/DRUG THERAPY Adult Cytomegalovirus Retinitis/DIAGNOSIS/DRUG THERAPY/*ETIOLOGY Diagnosis, Differential Drug Synergism Drug Therapy, Combination Foscarnet/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Ganciclovir/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Human Prognosis Zidovudine/ADMINISTRATION & DOSAGE/THERAPEUTIC USE JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDcomplications/drugtherapyadultcytomegalovirusretinitis/diagnosis/drugtherapy/
950228
M9521038

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .